CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Reckitt Benckiser Pharmaceuticals Inc. v. Alvogen Pine Brook Inc

1:13-cv-02003

Overview

Case Number 1:13-cv-02003
Filing Date 2013-12-06
Status Terminated
Termination Date 2014-05-09
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1338 Patent Infringement
Jury Demand None

Parties

Defendant

Alvogen Group Inc. Operating Company

Represented By

1 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Counter Claimant

Alvogen Pine Brook Inc. Operating Company

Represented By

6 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

Gregory C. Bays

Email: gbays@leydig.com

Elizabeth M. Crompton

Email: elizabethcrompton@parkerpoe.com

David Van Biskirk

Email: dvanbuskirk@leydig.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Steven H. Sklar

Email: ssklar@leydig.com

Counter Defendant

MonoSol Rx LLC Operating Company

Represented By

6 Attorneys Listed

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Stephanie L. Schonewald

Email: sschonew@steptoe.com

Timothy C. Bickham

Email: tbickham@steptoe.com

Houda Morad

UNDELIVERABLE EMAIL 4/1/15

James F. Hibey

Email: jhibey@steptoe.com

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

RB Pharmaceuticals Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Reckitt Benckiser Pharmaceuticals Inc. Operating Company

Represented By

4 Attorneys Listed

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Timothy P. Heaton

UNDELIVERABLE EMAIL 6/1/20

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Daniel A. Ladow

UNDELIVERABLE EMAIL 11/3/2020

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 20 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (20): 🇨🇦 Canada CN 🇪🇺 Europe 🇯🇵 Japan KR 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8475832
Sublingual and buccal film compositions
Filed: 2009-08-07
Issued: 2013-07-02
Active (3.3 yrs remaining) +231d PTA
Expires: 2030-03-26
US8017150
Polyethylene oxide-based films and drug delivery systems made therefrom
Filed: 2008-04-22
Issued: 2011-09-13
Expired (Term Ended)
Expires: 2023-10-10
US8603514
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Filed: 2007-07-10
Issued: 2013-12-10
Expired (Term Ended)
Expires: 2024-04-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+231 days) / Cellect Scrutiny — Over 231 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

15

Dispositive

8

Granted

2

Denied

0

Pending / Review

12

Motions by Category

Procedural / Extension Motion 6 Claim Construction / Markman Filing 1 Motion to Dismiss 8

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER Granting 51 MOTION to Dismiss the Amended Complaint and Counterclaims, filed by Reckitt Benckiser Pharmaceuticals Inc., MonoSol Rx LLC, RB Pharmaceuticals...
Entry #61 • 2014-05-09 Document →
Motion to Dismiss Pending / Under Review
[SEALED] Letter to The Honorable Richard G. Andrews from Jeffrey T. Castellano regarding Plaintiffs' Motion to Dismiss - re 52 Opening Brief in Support, 51 MOTI...
Entry #60 • 2014-05-07 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME for Alvogen to Respond to Plaintiffs' Motion to Dismiss [D.I. 51] to May 7, 2014 - filed by Alvogen Pine Brook Inc.. (Castellano, Jef...
Entry #58 • 2014-05-05 Document →
Motion to Dismiss Pending / Under Review
SO ORDERED, re 58 STIPULATION TO EXTEND TIME for Alvogen to Respond to Plaintiffs' 51 Motion to Dismiss to May 7, 2014, filed by Alvogen Pine Brook Inc. (Reset ...
Entry #59 • 2014-05-05 Document →
Motion to Dismiss Pending
MOTION to Dismiss the Amended Complaint and Counterclaims - filed by MonoSol Rx LLC, RB Pharmaceuticals Limited, Reckitt Benckiser Pharmaceuticals Inc.. (Attach...
Entry #51 • 2014-04-18 Document →
Motion to Dismiss Granted
MOTION to Dismiss the Amended Complaint and Counterclaims - filed by MonoSol Rx LLC, RB Pharmaceuticals Limited, Reckitt Benckiser Pharmaceuticals Inc.. (Attach...
Entry #51 • 2014-04-18 Document →

Docket Entries

(67 total)
Pleading / Complaint

COMPLAINT filed against Alvogen Group Inc., Alvogen Pine Brook Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1420227.) - filed by Reckitt Benckiser Pharmaceuticals Inc., RB Pharmaceuticals Limited, MonoSol Rx LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(els) (Entered: 12/06/2013)

Entry #1 • 2013-12-06
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 12/06/2013)

Entry #2 • 2013-12-06
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/28/13. Date of Expiration of Patent: 2/13/23, 3/26/30.Thirty Month Stay Deadline: 4/28/2016. (els) (Entered: 12/06/2013)

Entry #3 • 2013-12-06
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,475,832; 8,017,150;. (els) (Entered: 12/06/2013)

Entry #4 • 2013-12-06
1

Disclosure Statement pursuant to Rule 7.1 filed by RB Pharmaceuticals Limited, Reckitt Benckiser Pharmaceuticals Inc. identifying Other Affiliate Reckitt Benckiser Group plc, Other Affiliate Reckitt Benckiser plc, Other Affiliate JAB Holdings BV for RB Pharmaceuticals Limited; Other Affiliate Reckitt Benckiser Investments (2012) LLC, Other Affiliate Reckitt Benckiser USA (2012) LLC for Reckitt Benckiser Pharmaceuticals Inc.. (els) (Entered: 12/06/2013)

Entry #5 • 2013-12-06
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc